ClinicalTrials.gov
public full text
Public Domain
Adjunctive Glycine for Obsessive Compulsive Disorder
The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Epidiolex in Obsessive Compulsive Disorder and Related Disorders#866718
- Role of SAT1 glutamine transporter in the neurotransmission balance: implications for anxiety-related disorders#680122
- Mechanisms of transport and analgesic compounds recognition by glycine transporter 2.#223025
- BCAA Supplementation for Concussion#1095826
- Incidence of Gastrointestinal Adverse Events and Healthcare Resource Utilization in Patients Using Glucagon-Like Peptide-1 Analogs: A Real-World Study#977375
Record · ID 1008113
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive